172 related articles for article (PubMed ID: 15757066)
41. Operative intervention for recurrence of adrenocortical carcinoma: A single-center experience.
Zhang F; Liu Z; Liang J; Tang Y; Liu S; Zhou C; Zhang F; Wu K; Lu Y; Wang X
Surgery; 2021 May; 169(5):1131-1138. PubMed ID: 33279225
[TBL] [Abstract][Full Text] [Related]
42. Surgical management of adrenocortical carcinoma.
Ranvier GG; Inabnet WB
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
[TBL] [Abstract][Full Text] [Related]
43. Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence.
Amini N; Margonis GA; Kim Y; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
Ann Surg Oncol; 2016 Jan; 23(1):126-33. PubMed ID: 26282907
[TBL] [Abstract][Full Text] [Related]
44. Adrenocortical carcinoma: the range of appearances on CT and MRI.
Bharwani N; Rockall AG; Sahdev A; Gueorguiev M; Drake W; Grossman AB; Reznek RH
AJR Am J Roentgenol; 2011 Jun; 196(6):W706-14. PubMed ID: 21606258
[TBL] [Abstract][Full Text] [Related]
45. Adrenocortical carcinoma: clinicopathological features, prognostic factors and outcome.
Keskin S; Taş F; Vatansever S
Urol Int; 2013; 90(4):435-8. PubMed ID: 23343838
[TBL] [Abstract][Full Text] [Related]
46. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.
Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I
BMC Urol; 2015 May; 15():43. PubMed ID: 26013141
[TBL] [Abstract][Full Text] [Related]
47. The role of surgery in the management of recurrent adrenocortical carcinoma.
Erdogan I; Deutschbein T; Jurowich C; Kroiss M; Ronchi C; Quinkler M; Waldmann J; Willenberg HS; Beuschlein F; Fottner C; Klose S; Heidemeier A; Brix D; Fenske W; Hahner S; Reibetanz J; Allolio B; Fassnacht M;
J Clin Endocrinol Metab; 2013 Jan; 98(1):181-91. PubMed ID: 23150691
[TBL] [Abstract][Full Text] [Related]
48. Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.
Sung TY; Choi YM; Kim WG; Lee YM; Kim TY; Shong YK; Kim WB; Song DE
J Korean Med Sci; 2017 May; 32(5):764-771. PubMed ID: 28378549
[TBL] [Abstract][Full Text] [Related]
49. A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group.
Poorman CE; Ethun CG; Postlewait LM; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solórzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
Ann Surg Oncol; 2018 Feb; 25(2):520-527. PubMed ID: 29164414
[TBL] [Abstract][Full Text] [Related]
50. Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data.
Kerkhofs TM; Verhoeven RH; Bonjer HJ; van Dijkum EJ; Vriens MR; De Vries J; Van Eijck CH; Bonsing BA; Van de Poll-Franse LV; Haak HR;
Eur J Endocrinol; 2013 Jul; 169(1):83-9. PubMed ID: 23641018
[TBL] [Abstract][Full Text] [Related]
51. Clinical Score Predicting Overall Survival After Surgery for Synchronous Metastatic Adrenocortical Carcinoma: A Surveillance, Epidemiology, and End Result-Based Study.
Wu K; Liu Z; Li X; Lu Y
Am Surg; 2021 May; 87(5):805-811. PubMed ID: 33228399
[TBL] [Abstract][Full Text] [Related]
52. Adrenocortical carcinoma: surgical progress or status quo?
Kendrick ML; Lloyd R; Erickson L; Farley DR; Grant CS; Thompson GB; Rowland C; Young WF; van Heerden JA
Arch Surg; 2001 May; 136(5):543-9. PubMed ID: 11343545
[TBL] [Abstract][Full Text] [Related]
53. The use of FDG-PET and CT for the staging of adrenocortical carcinoma in children.
Kreissig R; Amthauer H; Krude H; Steinmueller P; Stroszczynski C; Hosten N; Grueters A; Felix R
Pediatr Radiol; 2000 May; 30(5):306. PubMed ID: 10836591
[No Abstract] [Full Text] [Related]
54. Adrenal adenocarcinoma: a review of 53 cases.
Zografos GC; Driscoll DL; Karakousis CP; Huben RP
J Surg Oncol; 1994 Mar; 55(3):160-4. PubMed ID: 8176925
[TBL] [Abstract][Full Text] [Related]
55. Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade.
Miller BS; Gauger PG; Hammer GD; Giordano TJ; Doherty GM
Langenbecks Arch Surg; 2010 Sep; 395(7):955-61. PubMed ID: 20694732
[TBL] [Abstract][Full Text] [Related]
56. [Pulmonary metastasis of sarcomatous component of adrenocortical carcinoma].
Ui A; Horio H; Murakami S; Harada M; Hijima T
Kyobu Geka; 2014 Nov; 67(12):1089-91. PubMed ID: 25391473
[TBL] [Abstract][Full Text] [Related]
57. Oncocytic subtypes of adrenal cortical carcinoma: Aggressive in appearance yet more indolent in behavior?
Mills JK; Khalil M; Pasieka J; Kong S; Xu Y; Harvey A
Surgery; 2019 Oct; 166(4):524-533. PubMed ID: 31472975
[TBL] [Abstract][Full Text] [Related]
58. [Malignant adrenocortical tumors. Apropos of 9 cases].
Benchekroun A; Benslimane L; Iken A; Chefchaouni MC; Faik M; Marzouk A
Ann Urol (Paris); 1996; 30(1):33-7. PubMed ID: 8712758
[TBL] [Abstract][Full Text] [Related]
59. Pulmonary resection for metastatic adrenocortical carcinoma: the National Cancer Institute experience.
Kemp CD; Ripley RT; Mathur A; Steinberg SM; Nguyen DM; Fojo T; Schrump DS
Ann Thorac Surg; 2011 Oct; 92(4):1195-200. PubMed ID: 21958764
[TBL] [Abstract][Full Text] [Related]
60. Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease.
Livhits M; Li N; Yeh MW; Harari A
Surgery; 2014 Dec; 156(6):1531-40; discussion 1540-1. PubMed ID: 25456949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
